CRMD – CorMedix Inc.
Float Short %
23.1
Margin Of Safety %
68
Put/Call OI Ratio
0.54
EPS Next Q Diff
0.02
EPS Last/This Y
2.94
EPS This/Next Y
-1.37
Price
7.03
Target Price
14.86
Analyst Recom
1
Performance Q
-30.22
Upside
279.1%
Beta
1.31
Ticker: CRMD
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-01-23 | CRMD | 7.28 | 0.43 | 0.20 | 56485 |
| 2026-01-26 | CRMD | 7.78 | 0.42 | 0.34 | 57227 |
| 2026-01-27 | CRMD | 7.76 | 0.43 | 0.46 | 58477 |
| 2026-01-28 | CRMD | 7.75 | 0.46 | 0.68 | 61734 |
| 2026-01-29 | CRMD | 8.04 | 0.49 | 0.34 | 66792 |
| 2026-01-30 | CRMD | 7.76 | 0.49 | 0.10 | 67975 |
| 2026-02-02 | CRMD | 8.18 | 0.47 | 0.19 | 71354 |
| 2026-02-03 | CRMD | 8.12 | 0.48 | 0.31 | 71304 |
| 2026-02-04 | CRMD | 7.84 | 0.48 | 0.38 | 71071 |
| 2026-02-05 | CRMD | 7.34 | 0.48 | 1.27 | 71568 |
| 2026-02-06 | CRMD | 7.68 | 0.48 | 0.71 | 71571 |
| 2026-02-09 | CRMD | 7.57 | 0.48 | 0.15 | 71860 |
| 2026-02-10 | CRMD | 7.7 | 0.47 | 0.08 | 72325 |
| 2026-02-11 | CRMD | 7.44 | 0.47 | 0.64 | 72707 |
| 2026-02-12 | CRMD | 7.36 | 0.46 | 0.15 | 72450 |
| 2026-02-13 | CRMD | 7.36 | 0.45 | 0.11 | 73206 |
| 2026-02-17 | CRMD | 7.27 | 0.45 | 2.94 | 74154 |
| 2026-02-18 | CRMD | 7.16 | 0.49 | 0.93 | 76151 |
| 2026-02-19 | CRMD | 7.07 | 0.53 | 2.17 | 76678 |
| 2026-02-20 | CRMD | 7.03 | 0.54 | 0.97 | 77439 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-01-23 | CRMD | 7.29 | 265.2 | - | 2.63 |
| 2026-01-26 | CRMD | 7.78 | 265.2 | - | 2.63 |
| 2026-01-27 | CRMD | 7.76 | 265.2 | - | 2.63 |
| 2026-01-28 | CRMD | 7.76 | 265.2 | - | 2.63 |
| 2026-01-29 | CRMD | 8.04 | 265.2 | - | 2.63 |
| 2026-01-30 | CRMD | 7.76 | 265.2 | - | 2.63 |
| 2026-02-02 | CRMD | 8.20 | 265.2 | - | 2.63 |
| 2026-02-03 | CRMD | 8.12 | 265.2 | - | 2.63 |
| 2026-02-04 | CRMD | 7.85 | 265.2 | - | 2.63 |
| 2026-02-05 | CRMD | 7.35 | 265.2 | - | 2.63 |
| 2026-02-06 | CRMD | 7.67 | 265.2 | - | 2.63 |
| 2026-02-09 | CRMD | 7.58 | 268.2 | - | 2.63 |
| 2026-02-10 | CRMD | 7.70 | 268.2 | - | 2.63 |
| 2026-02-11 | CRMD | 7.45 | 268.2 | - | 2.63 |
| 2026-02-12 | CRMD | 7.37 | 268.2 | - | 2.63 |
| 2026-02-13 | CRMD | 7.34 | 268.2 | - | 2.63 |
| 2026-02-17 | CRMD | 7.22 | 268.2 | - | 2.63 |
| 2026-02-18 | CRMD | 7.17 | 268.2 | - | 2.63 |
| 2026-02-19 | CRMD | 7.07 | 268.2 | - | 2.63 |
| 2026-02-20 | CRMD | 7.03 | 268.2 | - | 2.63 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-01-23 | CRMD | -3.81 | 13.63 | 24.10 |
| 2026-01-26 | CRMD | -3.81 | 13.52 | 24.10 |
| 2026-01-27 | CRMD | -3.81 | 13.52 | 24.10 |
| 2026-01-28 | CRMD | -3.82 | 13.52 | 25.82 |
| 2026-01-29 | CRMD | -3.82 | 13.52 | 25.82 |
| 2026-01-30 | CRMD | -3.82 | 13.52 | 25.82 |
| 2026-02-02 | CRMD | -3.82 | 13.78 | 26.06 |
| 2026-02-03 | CRMD | -3.58 | 13.78 | 26.06 |
| 2026-02-04 | CRMD | -3.58 | 13.78 | 26.06 |
| 2026-02-05 | CRMD | -3.58 | 13.78 | 26.06 |
| 2026-02-06 | CRMD | -3.58 | 13.78 | 26.06 |
| 2026-02-09 | CRMD | -3.58 | 13.09 | 26.06 |
| 2026-02-10 | CRMD | -3.58 | 13.09 | 26.06 |
| 2026-02-11 | CRMD | -3.58 | 13.09 | 23.79 |
| 2026-02-12 | CRMD | -3.58 | 13.09 | 23.85 |
| 2026-02-13 | CRMD | -3.53 | 13.09 | 23.85 |
| 2026-02-17 | CRMD | -3.53 | 20.55 | 23.85 |
| 2026-02-18 | CRMD | -3.53 | 20.55 | 23.85 |
| 2026-02-19 | CRMD | -3.53 | 20.55 | 23.85 |
| 2026-02-20 | CRMD | -3.53 | 20.55 | 23.10 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
0.57
Avg. EPS Est. Current Quarter
0.7
Avg. EPS Est. Next Quarter
0.59
Insider Transactions
-3.53
Institutional Transactions
20.55
Beta
1.31
Average Sales Estimate Current Quarter
127
Average Sales Estimate Next Quarter
108
Fair Value
11.81
Quality Score
99
Growth Score
42
Sentiment Score
29
Actual DrawDown %
60.8
Max Drawdown 5-Year %
-84.5
Target Price
14.86
P/E
3.42
Forward P/E
5.69
PEG
P/S
2.58
P/B
1.47
P/Free Cash Flow
7.44
EPS
2.05
Average EPS Est. Cur. Y
2.63
EPS Next Y. (Est.)
1.27
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
75.83
Relative Volume
0.69
Return on Equity vs Sector %
14.4
Return on Equity vs Industry %
31.9
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
CorMedix Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 64
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.
stock quote shares CRMD – CorMedix Inc. Stock Price stock today
news today CRMD – CorMedix Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch CRMD – CorMedix Inc. yahoo finance google finance
stock history CRMD – CorMedix Inc. invest stock market
stock prices CRMD premarket after hours
ticker CRMD fair value insiders trading